We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Available Volunteer Opportunities Call for Nominations – Board of Directors After evaluating the strengths of the existing Board of Directors, the Board Development Committee is seeking individuals with the following […]

Our Leadership Our Senior Team Meet the members of the Senior Team at Osteoporosis Canada who are committed and passionate about their work in creating a Canada without osteoporotic fractures […]

Latest News CIHR Institute of Aging Award Winners for 2022-2023 November 7, 2023 Congratulations to Dr. Alexandra Papaioannou, member of the Osteoporosis Canada Scientific Advisory Council (SAC) is one of […]

Dr. Mohit Bhandari, a member of the SAC Executive committee,  a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]

Latest News Dr. Angela Man-Wei Cheung ISCD 2024 Board Announcement April  19, 2024 The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, […]

Community Backbone Award Submission Form Award Criteria The Community Backbone Award is presented annually to individuals who: Are considered integral to the organization by proving their commitment to the mission […]

The release of the Osteoporosis Canada 2023 Clinical Practice Guideline will support Canadian healthcare providers in providing the most current evidence-based information for patient centred care to optimise skeletal health […]